exagamglogene autotemcel
CRISPR,Vertex
['pivotal trial', '$vrtx']
positive results from pivotal trials of exa-cel for transfusion-dependent beta thalassemia and severe sickle cell disease presented at the 2023 annual european hematology association (eha) congress - health stocks hub $vrtx 
Real-Time News, Market Data, Insider Trades, and Stock Quotes for Biotech, Pharma, Medical, and Healthcare Stocks @ https://t.co/Oqp6BRBKy2